Heba Nowyhed
Analista de Capital Privado en VV Manager LLC .
Origen de la red de primer grado Heba Nowyhed.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts.
15
| Private Company | Investment Managers | 15 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Heba Nowyhed a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | Investment Managers | Director/Board Member Corporate Officer/Principal | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Founder Chairman Private Equity Investor | |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Founder Director/Board Member | |
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member Director/Board Member | |
Riverbank Capital Securities, Inc.
 Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
TPG Capital LLC
 TPG Capital LLC Investment ManagersFinance TPG Capital LLC is a Private Equity firm, a subsidiary of TPG Capital Advisors LLC founded in 1992 by William S. Price and James George Coulter. The firm is headquartered in Fort Worth with additional offices in London and São Paulo. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| University of Oxford | College/University | Doctorate Degree Undergraduate Degree | |
| Orion Biomedical Fund LP | Corporate Officer/Principal Chief Investment Officer | ||
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| TPG Biotechnology Partners LP | Investment Managers | Founder | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder Chairman | |
Novotech (Australia) Pty Ltd.
 Novotech (Australia) Pty Ltd. BiotechnologyHealth Technology Novotech (Australia) Pty Ltd. operates as a contract research organization. It provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services and central lab services. The firm offers patient recruitment and site selection, clinical operations and project management, medical and regulatory consulting, biometrics and data management solutions. The company was founded by Alek Safarian in 1996 and is headquartered in Sydney, Australia. | Biotechnology | Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Founder Founder Chief Executive Officer Private Equity Investor Investor Relations Contact Private Equity Investor | |
| David Geffen School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| UROGEN PHARMA LTD. | Biotechnology | Chairman Director/Board Member Consultant / Advisor Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Two River Consulting LLC
 Two River Consulting LLC Miscellaneous Commercial ServicesCommercial Services Two River Consulting LLC provides management consulting services. The private company is based in Franklin Lakes, NJ. The company was founded by David M. Tanen. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Biotechnology | Director/Board Member Founder Corporate Officer/Principal | |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Vida Ventures LLC invests in companies located in the United States. The fund targets companies operating in the fields of life science innovation. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Founder Founder Director/Board Member Founder | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Founder Founder Founder General Counsel Founder | |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Founder Founder Founder Chief Executive Officer Consultant / Advisor | |
ByHeart, Inc.
 ByHeart, Inc. Miscellaneous Commercial ServicesCommercial Services ByHeart, Inc. engages in the provision of healthcare business. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Neogene Therapeutics, Inc. engages in the provision T cell therapies to treat cancer. The company was founded by Ton N. M. Schumacher and Carsten Linnemann and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
105 W First Street LLC
 105 W First Street LLC Real Estate Investment TrustsFinance 105 W First Street LLC engages in real estate industry. The company was founded in 2019 and is headquartered in New York, NY. | Real Estate Investment Trusts | Director/Board Member Director/Board Member | |
| KYVERNA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Breakthrough Properties LLC
 Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC engages in the provision of real estate development services. It offers best-in-class physical infrastructure, user-driven perspective, and mentorship. The company was founded by Dan Belldegrun and is headquartered in Los Angeles, CA. | Investment Managers | Director/Board Member Chairman | |
| Acrostar Pharmaservices Corp. | Director/Board Member | ||
| Breakthrough Services LLC | Director/Board Member Chairman | ||
Novotech Holdings Pty Ltd.
 Novotech Holdings Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Novotech Health Holdings engages in the development of contract research organization platform. The company was founded on October 12, 2020 and is headquartered in Australia. | Miscellaneous Commercial Services | Director/Board Member | |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Biotechnology | Founder Founder Director/Board Member Chairman | |
| Novotech Aus Holdco Pty Ltd. | Director/Board Member | ||
Novotech Health Holdings Ltd.
 Novotech Health Holdings Ltd. BiotechnologyHealth Technology Novotech Health Holdings Ltd. operates as a biotech-focused full-service contract research organization. Its integrated CRO platform provides clinical trial services ranging from consulting services prior to the commencement of the clinical phase to late-phase clinical trials. The firm’s services include: clinical trial services which include clinical research, bioequivalence and pharmacodynamics research, and drug development consulting services; and its related clinical trial services which include laboratory, site management organization, flexible insourcing and Phase I clinical trial unit services. The company was founded on February 25, 2020 and is headquartered in Singapore. | Biotechnology | Director/Board Member | |
Roka Bioscience, Inc.
 Roka Bioscience, Inc. BiotechnologyHealth Technology Roka Bioscience, Inc. is a company that specializes in food safety technology. The company is based in Mendham, NJ and was founded in 2009 by Paul G. Thomas. Roka Bioscience's core technology is their pathogen detection assays which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to target ribosomal RNA (rRNA), an optimal target for molecular technology in food pathogen detection applications. The company offers a range of products including the Atlas® System and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bioscience also provides environmental testing solutions and technical support for their customers. Mary Duseau has been the CEO of the company since 2015. | Biotechnology | Director/Board Member | |
D3C1 Allston Co-Investment LP
 D3C1 Allston Co-Investment LP Financial ConglomeratesFinance Part of Breakthrough Properties LLC, D3C1 Allston Co-Investment LP functions as an investment fund. The company is based in Los Angeles, CA. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Monograph Capital Partners I LP
 Monograph Capital Partners I LP Investment ManagersFinance Monograph Capital Partners I LP invests in companies located in North America and Europe primarily in the United Kingdom. The fund targets companies operating in the fields of life sciences. It provides financing for early-stage capital requirements. | Investment Managers | Founder | |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Founder Founder | |
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 44 |
| Australia | 4 |
| Hong-Kong | 2 |
| Reino Unido | 2 |
| China | 2 |
Sectorial
| Health Technology | 27 |
| Finance | 13 |
| Consumer Services | 5 |
| Commercial Services | 5 |
Operativa
| Director/Board Member | 164 |
| Corporate Officer/Principal | 45 |
| Founder | 40 |
| Private Equity Investor | 29 |
| Independent Dir/Board Member | 29 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Fred Cohen | 58 |
| Joshua Kazam | 43 |
| Arie Belldegrun | 42 |
| Helen Kim | 33 |
| David Tanen | 25 |
| David Chang | 16 |
| Arjun Goyal | 16 |
| Stefan Vitorovic | 15 |
| Norbert W. Bischofberger | 11 |
| Christine Cassiano | 11 |
| Dinah Sah | 8 |
| Jean-Philippe Kouakou-Zebouah | 6 |
| Rajul Jain | 5 |
| Eric Trac | 4 |
| Kate Bechtold | 3 |
- Bolsa de valores
- Insiders
- Heba Nowyhed
- Conexiones Empresas
